Know Cancer

or
forgot password

    • cancer clinical trials in urbana, IL

    • Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Carle Clinic-Urbana Main
    Urbana, Illinois 61801
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Carle Foundation dba Carle Cancer Center

    Trial Locations
    Carle Foundation dba Carle Cancer Center
    Carle Clinic-Urbana Main
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Carle Foundation - Carle Cancer Center
    Urbana, Illinois 61801
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Carle Foundation dba Carle Cancer Center

    Trial Locations
    Carle Foundation dba Carle Cancer Center
    Carle Clinic-Urbana Main
    Recurrent Mantle Cell Lymphoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Carle Clinic-Urbana Main

    Trial Locations
    Carle Clinic-Urbana Main
    Carle Foundation - Carle Cancer Center
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Fallopian Tube Cancer, Ovarian Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Carle Foundation - Carle Cancer Center
    Urbana, Illinois 61801
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Carle Foundation dba Carle Cancer Center

    Trial Locations
    Carle Foundation dba Carle Cancer Center
    Carle Clinic-Urbana Main
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Head and Neck Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Carle Clinic-Urbana Main

    Trial Locations
    Carle Clinic-Urbana Main
    Carle Foundation - Carle Cancer Center
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
    Carle Clinic-Urbana Main

    Trial Locations
    Carle Clinic-Urbana Main
    Carle Foundation - Carle Cancer Center
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
    Carle Clinic-Urbana Main

    Trial Locations
    Carle Clinic-Urbana Main
    Carle Foundation - Carle Cancer Center
    Gastrointestinal Stromal Tumor
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Carle Foundation - Carle Cancer Center
    Urbana, Illinois 61801
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Carle Clinic-Urbana Main

    Trial Locations
    Carle Clinic-Urbana Main
    Carle Foundation - Carle Cancer Center
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Carle Clinic-Urbana Main

    Trial Locations
    Carle Clinic-Urbana Main
    Carle Foundation - Carle Cancer Center
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Carle Clinic-Urbana Main

    Trial Locations
    Carle Clinic-Urbana Main
    Carle Foundation - Carle Cancer Center
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Carle Foundation - Carle Cancer Center
    Urbana, Illinois 61801
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Lung Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    CCOP - Carle Cancer Center
    Urbana, Illinois 61801
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Carle Clinic-Urbana Main
    Urbana, Illinois 61801
    Endometrial Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Carle Clinic-Urbana Main

    Trial Locations
    Carle Clinic-Urbana Main
    Carle Foundation - Carle Cancer Center
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Breast Cancer